Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental healthcare company advancing innovative treatments and...
Stay updated with breaking news from Emma Hapke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental healthcare company advancing innovative treatments and...
FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 30, 2022 /PRNewswire/ -- Depression and anxiety affect millions around the world and the venom of a toad is the
/PRNewswire/ -- Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic compound being used as an alternative...
Canadian tech entrepreneur and venture capitalist Sanjay Singhal gives $5 million to help launch a new psychedelic psychotherapy research centre for mental health at Toronto’s University Health Network.